In its ongoing mission to find the next Wegovy, Novo Nordisk has penned another partnership to seek out next-gen obesity treatments. This time, it's a $600 million biobucks pact with Flagship-founded ...

Owl butterflies amazingly ward off foes by disguising themselves as owls, thanks to wings that mirror the eyes of the woodland air predators. Flagship Pioneering is looking to build a new class of ...

(Reuters) -Novo Nordisk signed a research tie-up with U.S. biotech firm Metaphore on Thursday to develop next-generation obesity drugs. WHY IT'S IMPORTANT Danish drugmaker Novo is trying to expand ...

An owl butterfly is not speedy in flight, but the sight of its wings makes creatures think twice about making it a quick meal. The wing pattern resembles the eye of an owl. This ability to mimic a top ...

The company's MIMiC™ platform drives unprecedented insights into molecular interactions to design new biomolecules precisely tuned for therapeutic benefit With $50 million in committed capital from ...

CAMBRIDGE, Mass., Sept. 9, 2025 /PRNewswire/ -- Metaphore Biotechnologies, a Flagship Pioneering-founded generative AI drug design company focused on creating a new class of functional antibodies, ...

Imitation is not just the sincerest form of flattery. When combined with machine learning, molecular mimicry is how Metaphore Biotechnologies designs novel treatments in autoimmune disease, ...

CAMBRIDGE, Mass., Nov. 20, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel ...

After two years of development at Flagship Pioneering, start-up Metaphore Biotechnologies emerged on May 16 with $50 million of series A funding. It plans to tackle autoimmune and metabolic diseases ...

Last year, Daisuke Kawaguchi began his own personal venture into fashion with his label METAPHORE. Having spent close to a decade working under SOPHNET. and its founder Hirofumi Kiyonaga, we asked ...